(PDF) Economic Consequences of Investing in Anti-HCV

Economic Consequences of Investing in Anti-HCV Antiviral Treatment From the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data

PharmacoEconomics - United Kingdom

doi 10.1007/s40273-018-0733-3

Full Text

Abstract

Available in full text

Categories

Occupational Health

Date

October 30, 2018

Authors

Andrea Marcellusi

Loreta A. Kondili

Francesco Saverio Mennini

Publisher

Springer Science and Business Media LLC

Related search

Pin79 - Economic Consequences of Anti-HCV Antiviral Treatment Investment From the NHS Perspective: A Real-World-Based Analysis From Piter Data

Value in Health

Occupational Health

English

Prm82 - Real World Evidence (Rwe) From Italian NHS-Aifa Registries

Value in Health

Occupational Health

English

Antiplatelet Treatment in Acute Coronary Syndrome Patients: Real-World Data From the START-Antiplatelet Italian Registry

Multidisciplinary

English

Php328 - Real-World-Data and Real-World-Evidence State of Art From a Literature Review Perspective

Value in Health

Occupational Health

English

Pin44 Real-World Evaluation of the Economic Impact of Duration of Drug Therapy in the Treatment of Hepatitis C Virus (Hcv)

Value in Health

Occupational Health

English

The Economic Meaning of Data Envelopment Analysis: A ‘Behavioral’ Perspective

Socio-Economic Planning Sciences

Management Science

Operations Research

English

The Medical Treatment With Pasireotide in Cushing’s Disease: An Italian Multicentre Experience Based on “Real-World Evidence”

English

Treatment of Hepatitis C Genotype 1 Infection in Germany: Effectiveness and Safety of Antiviral Treatment in a Real-World Setting

United European Gastroenterology Journal

Gastroenterology

English

The “Real-World” Efficacy and Safety of DAAs for the Treatment of HCV Patients Throughout Japan

Journal of Gastroenterology

Gastroenterology

English